SCHEMBL5333350

SCHEMBL5333350

Cc1ncc2sccc2c1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.50
MAPT P10636 4/20 0.44
HTT P42858 3/20 0.44
ALDH1A1 P00352 2/20 0.44
HPGD P15428 2/20 0.44
PPARG P37231 1/20 0.44
NCOA2 Q15596 1/20 0.44
NCOA1 Q15788 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
NCOA3 Q9Y6Q9 1/20 0.44
LMNA P02545 2/20 0.43
ICAM1 P05362 1/20 0.38
SELE P16581 1/20 0.38
VCAM1 P19320 1/20 0.38
DYRK1A Q13627 1/20 0.37
CYP2A6 P11509 1/20 0.36
GAA P10253 1/20 0.30
NPC1 O15118 1/20 0.30
RAB9A P51151 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14498848 0.80 KDM4E (0.53) KDM4EMAPTHTTALDH1A1HPGD
SCHEMBL3783881 0.78 KDM4E (0.46) KDM4EMAPTHTTALDH1A1HPGD
SCHEMBL20744991 0.77 KDM4E (0.44) KDM4EMAPTHTTALDH1A1HPGD
SCHEMBL15691397 0.73 KDM4E (0.46) KDM4EMAPTHTTALDH1A1HPGD
SCHEMBL20745918 0.71 KDM4E (0.38) KDM4EMAPTHTTALDH1A1HPGD
SCHEMBL5376106 0.71 ALDH1A1 (0.32) KDM4EMAPTALDH1A1NPC1RAB9A
SCHEMBL20745951 0.70 KDM4E (0.40) KDM4EMAPTHTTALDH1A1HPGD
SCHEMBL18876006 0.69 CYP2A6 (0.42) KDM4EMAPTHTTALDH1A1ICAM1
SCHEMBL370633 0.69 DYRK1A (0.53) KDM4EMAPTHTTALDH1A1HPGD
SCHEMBL14438006 0.68 KDM4E (0.44) KDM4EMAPTHTTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2539344-A1 HALOGEN OR CYANO SUBSTITUTED THIENO [2,3-D]PYRIMIDINES HAVING MNK1/MNK2 INHIBITING ACTIVITY FOR PHARMACEUTICAL COMPOSITIONS Boehringer Ingelheim International GmbH (DE) 2013-01-02 EP disclosed
WO-2007056215-A9 N-ARYL-THIENOPYRIMIDIN-4-AMINES AND THE USE THEREOF CYTOVIA INC (US) 2007-09-13 WO disclosed
WO-2007056215-A2 N-ARYL-THIENOPYRIMIDIN-4-AMINES AND THE USE THEREOF CYTOVIA, INC. (US) 2007-05-18 WO disclosed